<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1569">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04385160</url>
  </required_header>
  <id_info>
    <org_study_id>FROM - O-MPN-COVID-2020</org_study_id>
    <nct_id>NCT04385160</nct_id>
  </id_info>
  <brief_title>Myeloproliferative Neoplasms (MPN) and COVID-19</brief_title>
  <acronym>MPN-COVID</acronym>
  <official_title>Myeloproliferative Neoplasms (MPN) and COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione per la Ricerca Ospedale Maggiore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Leukemia Net</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione per la Ricerca Ospedale Maggiore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An increased risk of both venous and arterial thromboembolism was noted in reports from
      SARS-CoV-2-infected patients in China and has been confirmed in autopsy findings from
      patients who experienced sudden death. Myeloproliferative Neoplasms (MPNs), which encompass
      polycythemia vera, essential thrombocythemia and primary myelofibrosis, are thrombophilic
      disorders with a natural propensity to thrombosis that is fuelled by the intrinsic activation
      of inflammatory cytokines. It therefore follows that an underlying diagnosis of MPN may
      increase the risk of worse clinical outcomes and death during periods of active Covid-19
      disease. This ambispective, observational study aims to elucidate the key factors which
      affect the clinical course of patients with MPN who develop Covid-19 disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an European multicenter observational study that will include around 80 MPN patients
      with a confirmed diagnosis of Covid-19 will be followed for at least one month. Detailed
      information on the clinical characteristics of these patients and their disease outcomes will
      be retrospectively and prospectively collected in a specific eCRF, including MPN
      characteristics, treatment and comorbidities pre-Covid-19, time of Covid-19 diagnosis,
      drugs/device used for the treatment of Covid-19, any change in MPN therapy, antithrombotic
      prophylaxis employed during the period of infection and - for hospitalised patients only -
      key blood and laboratory parameters. A particular focus will be on exploring final outcomes
      for patients in this study, most notably the incidence of fatal and non-fatal thrombotic
      events. Statistical analyses will also be performed looking for any independent factors that
      can significantly predict patient outcomes after Covid-19 diagnosis.

      Ultimately, this project will provide important insights into disease severity and
      progression in patients with MPN and Covid-19 and uncover the key clinical factors which
      drive outcomes and mortality. Results may help clinicians better understand how patient
      characteristics and management decisions can impact on disease trajectory when MPN and
      Covid-19 collide.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 13, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pulmonary embolism (PE)</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Incidence of cases of MPN patients with COVID-19 experiencing pulmonary embolism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fatal or non fatal thrombotic event</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Incidence of cases reporting at least one fatal or non fatal thrombotic event reported in therapy of MPN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous Positive Airway Pressure (CPAP)</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Incidence of cases reporting at least one COVID-19 worsening outcome as Continuous Positive Airway Pressure (CPAP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>invasive ventilation</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Incidence of cases reporting at least one COVID-19 worsening outcome as invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>admission in Intensive Care Unit (ICU)</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Incidence of cases reporting at least one COVID-19 worsening outcome as Intensive Care Unit (ICU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>2 and a half months</time_frame>
    <description>incidence of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>treatments and interventions applied for MPN</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Type of treatments and interventions applied for MPN during COVID-19 and any change reported in therapy of MPN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>treatments and interventions applied for COVID-19</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Type of treatments and interventions applied for COVID-19</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thrombotic events association to patients characteristic and treatments</measure>
    <time_frame>2 and a half months</time_frame>
    <description>Odds Ratios (ORs) of the outcome and 95% Confidence Intervals (CIs) associated with patients' characteristics and treatments</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Myeloproliferative Neoplasm</condition>
  <condition>COVID</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Myeloproliferative Neoplasm (Polycythemia Vera, Essential Polycythemia,
        Myelofibrosis) diagnosed with COVID-19 between 15 February 2020 and 31 May 2020
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Confirmed diagnosed of MPN according to WHO criteria

          -  Diagnosis of COVID-19 based by the positivity of oropharyngeal swab performed between
             15 February up to 31 May 2020

          -  Active follow-up until 30 June 2020

          -  Signed informed consent

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiziano Barbui, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione per la Ricerca Ospedale di Bergamo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arianna Masciulli, PharmD</last_name>
    <phone>0352678926</phone>
    <email>amasciulli@fondazionefrom.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessandra Carobbio, BioStat</last_name>
    <email>acarobbio@fondazionefrom.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York-Presbyterian/Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen K Ritchie</last_name>
    </contact>
    <investigator>
      <last_name>Ellen K Ritchie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Jacques Kiladjian</last_name>
      <email>jean-jacques.kiladjian@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Jacques Kiladjian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center RWTH</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffen Koschmieder</last_name>
      <email>skoschmieder@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Steffen Koschmieder</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center</name>
      <address>
        <city>Minden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kai Wille</last_name>
      <email>kai.wille@muehlenkreiskliniken.de</email>
    </contact>
    <investigator>
      <last_name>Martin Griesshammer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai Wille</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Gerardo di Monza</name>
      <address>
        <city>Monza</city>
        <state>Monza Brianza</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania Priolo</last_name>
      <email>s.priolo.hsg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Elena Elli</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrizio Cavalca</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.S.O. SS. Antonio e Biagio e C.Arrigo di Alessandria</name>
      <address>
        <city>Alessandria</city>
        <zip>15121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monia Marchetti</last_name>
      <email>moniamarchettitamellini@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Monia Marchetti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST-Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Luisa Ferrari</last_name>
      <email>mlferrari@fondazionefrom.it</email>
    </contact>
    <contact_backup>
      <last_name>Federica Delaini</last_name>
      <email>ematologia.ricerca@asst-pg23.it</email>
    </contact_backup>
    <investigator>
      <last_name>Alessandro Rambaldi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico S.Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Federica D'Ambrosio</last_name>
      <email>federica.dambrosio3@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Francesca Palandri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST-Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Daffini</last_name>
      <email>ctoematologia.brescia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Rossi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosa Daffini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Ospedale Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Paoli</last_name>
      <email>chiara.paoli@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Paola Guglielmelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessandro M Vannucchi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Artuso</last_name>
      <email>silvia.artuso@policlinico.mi.it</email>
    </contact>
    <investigator>
      <last_name>Alessandra Iurlo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Piazzolla</last_name>
      <email>piazzolla.daniela@hsr.it</email>
    </contact>
    <contact_backup>
      <last_name>Stefania Trinca</last_name>
      <email>trinca.stefania@hsr.it</email>
    </contact_backup>
    <investigator>
      <last_name>Fabio Ciceri</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesca Lunghi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara De Ambrogi</last_name>
      <email>clara.deambrogi@med.uniupo.it</email>
    </contact>
    <investigator>
      <last_name>Andrea Patriarca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosalba Sciancalepore</last_name>
      <email>&quot;SciancalR.Sciancalepore@smatteo.pv.it</email>
    </contact>
    <investigator>
      <last_name>Elisa Rumi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniele Vanni</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Fondazione Agostino Gemelli</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Soldati</last_name>
      <email>denise_soldati@outlook.it</email>
    </contact>
    <contact_backup>
      <last_name>Giulia Desa</last_name>
      <email>g.desa@hotmail.it</email>
    </contact_backup>
    <investigator>
      <last_name>Valerio De Stefano</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Rossi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Betti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Città della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Pirillo</last_name>
      <email>fpirillo@cittadellasalute.to.it</email>
    </contact>
    <investigator>
      <last_name>Giulia Benevolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Policlinico &quot;G.B. Rossi&quot; Borgo Roma</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Scaffidi</last_name>
      <email>scaffidi.luigi@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Massimiliano Bonifacio</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luigi Scaffidi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilia Florea</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bortolo</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilaria Nichele</last_name>
      <email>ilaria.nichele@aulss8.veneto.it</email>
    </contact>
    <investigator>
      <last_name>Marco Ruggeri</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luigi Scaffidi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilaria Nichele</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sobas Wroclaw Medical University ·</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Anna Sobas, MD</last_name>
      <email>marta.sobas@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marta Anna Sobas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic De Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Barcellona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Alvarez Larran</last_name>
      <email>AALVAR@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Alberto Alvarez Larran</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <state>Barcellona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcio Miguel Andrade Campos</last_name>
      <email>mandrade@hospitaldelmar.cat</email>
    </contact>
    <investigator>
      <last_name>Marcio Miguel Andrade Campos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Català d' Oncologia - Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blanca Xicoy Cirici</last_name>
      <email>bxicoy@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Blanca Xicoy Cirici</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO L'Hospitalet - Hospital Moisès Broggi</name>
      <address>
        <city>Sant Joan Despí</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Sagüés Serrano</last_name>
      <email>msagues@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Miguel Sagüés Serrano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Príncipe de Asturias</name>
      <address>
        <city>Alcalá De Henares</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Magro Mazo</last_name>
      <email>elenamagromazo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Elena Magro Mazo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de La Palma</name>
      <address>
        <city>Breña Alta</city>
        <state>Santa Cruz De Tenerife</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Tapia Torres</last_name>
      <email>Plaqueta2@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María Tapia Torres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Hematología Hospital General Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Marín Sánchez</last_name>
      <email>pibems@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Marín Sánchez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Elche</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma López Abadía</last_name>
      <email>emloab23@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Emma López Abadía</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Fox</last_name>
      <email>mlfox@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Laura Fox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatriz Cuevas</last_name>
      <email>bcuevas@hubu.es</email>
    </contact>
    <investigator>
      <last_name>Beatriz Cuevas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO Girona Hospital Josep Trueta Servei d'hematologia</name>
      <address>
        <city>Girona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Angona</last_name>
      <email>angona.figueras@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Anna Angona</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FEA Hematología Hospital Universitario de Móstoles</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keina Susana Quiroz Cervantes</last_name>
      <email>keinaquiroz@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Keina Susana Quiroz Cervantes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gonzalo Carreño</last_name>
      <email>gonzalo.carreno.gomeztarragona@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gonzalo Carreño</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petros Papadopoulos</last_name>
      <email>petros.papadopoulos@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Petros Papadopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santiago Osorio</last_name>
      <email>sanosorio2000@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Santiago Osorio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Moncloa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Begoña Navas Elorza</last_name>
      <email>b.navaselorza@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Begoña Navas Elorza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentin Garcia Gutierrez</last_name>
      <email>jvalentingg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Valentin Garcia Gutierrez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Angeles Foncillas, MD</last_name>
      <email>mafoncillas@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Angeles Foncillas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Gasior Kabat</last_name>
      <email>mercedesgasior@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mercedes Gasior Kabat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Hernández Boluda</last_name>
      <email>hernandez_jca@gva.es</email>
    </contact>
    <investigator>
      <last_name>Juan Carlos Hernández Boluda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas' NHS Foundation Trust.</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Harrison</last_name>
      <email>Claire.Harrison@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Claire Harrison</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 11, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Myeloproliferative Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Each participant can visualize its own data on eCRF after the completion patient's electronic data form.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

